|
US4898733A
(en)
*
|
1985-11-04 |
1990-02-06 |
International Minerals & Chemical Corp. |
Layered, compression molded device for the sustained release of a beneficial agent
|
|
US4662880A
(en)
*
|
1986-03-14 |
1987-05-05 |
Alza Corporation |
Pseudoephedrine, brompheniramine therapy
|
|
US4948592A
(en)
*
|
1986-05-09 |
1990-08-14 |
Alza Corporation |
Pulsed drug delivery
|
|
US5200196A
(en)
*
|
1986-05-09 |
1993-04-06 |
Alza Corporation |
Improvement in pulsed drug therapy
|
|
US4986987A
(en)
*
|
1986-05-09 |
1991-01-22 |
Alza Corporation |
Pulsed drug delivery
|
|
US4842867A
(en)
*
|
1986-05-09 |
1989-06-27 |
Alza Corporation |
Pulsed drug delivery of doxylamine
|
|
ES2038669T3
(es)
*
|
1986-09-18 |
1993-08-01 |
London School Of Pharmacy Innovations Ltd |
Formulacion farmaceutica.
|
|
US4810502A
(en)
*
|
1987-02-27 |
1989-03-07 |
Alza Corporation |
Pseudoephedrine brompheniramine therapy
|
|
US4915952A
(en)
*
|
1987-02-27 |
1990-04-10 |
Alza Corporation |
Composition comprising drug, HPC, HPMC and PEO
|
|
US5023076A
(en)
*
|
1987-02-27 |
1991-06-11 |
Alza Corporation |
Lamina comprising carboxyvinyl polymer
|
|
US4792448A
(en)
*
|
1987-06-11 |
1988-12-20 |
Pfizer Inc. |
Generic zero order controlled drug delivery system
|
|
DE3721574A1
(de)
*
|
1987-06-30 |
1989-01-12 |
Kettelhack Riker Pharma Gmbh |
Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
|
|
US4876093A
(en)
*
|
1987-07-02 |
1989-10-24 |
Alza Corporation |
Dispenser with dispersing member for delivering beneficial agent
|
|
US4824675A
(en)
*
|
1987-07-13 |
1989-04-25 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
|
US4837111A
(en)
*
|
1988-03-21 |
1989-06-06 |
Alza Corporation |
Dosage form for dispensing drug for human therapy
|
|
US4892739A
(en)
*
|
1988-04-25 |
1990-01-09 |
Ciba-Geigy Corporation |
Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
|
|
GB8820353D0
(en)
*
|
1988-08-26 |
1988-09-28 |
Staniforth J N |
Controlled release tablet
|
|
US5612059A
(en)
*
|
1988-08-30 |
1997-03-18 |
Pfizer Inc. |
Use of asymmetric membranes in delivery devices
|
|
US5067960A
(en)
*
|
1989-12-06 |
1991-11-26 |
Medtronic, Inc. |
Muscle fitness detection by colorimetry
|
|
ES2067957T3
(es)
*
|
1990-08-07 |
1995-04-01 |
Pfizer |
Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
|
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
|
US6764697B1
(en)
*
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
|
US5407686A
(en)
*
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
|
DE4217104A1
(de)
*
|
1992-05-22 |
1993-11-25 |
Salama Magdy |
Reservoir, Reservoir-System zur Inaktivierung, Hemmung und Eliminierung von Infektionserregern
|
|
US5660848A
(en)
*
|
1994-11-02 |
1997-08-26 |
The Population Council, Center For Biomedical Research |
Subdermally implantable device
|
|
US6039975A
(en)
*
|
1995-10-17 |
2000-03-21 |
Hoffman-La Roche Inc. |
Colon targeted delivery system
|
|
US6361796B1
(en)
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
|
WO1998018452A1
(en)
*
|
1996-10-25 |
1998-05-07 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
|
US6099862A
(en)
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
MXPA02006335A
(es)
|
1999-12-23 |
2002-12-13 |
Pfizer Prod Inc |
Forma de dosificacion de farmaco en capas impulsada por hidrogel.
|
|
US6669954B2
(en)
|
2000-01-25 |
2003-12-30 |
John R. Crison |
Controlled release of drugs
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
|
WO2002100318A2
(en)
|
2001-06-12 |
2002-12-19 |
Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
WO2003096968A2
(en)
*
|
2002-05-15 |
2003-11-27 |
Sun Pharmaceutical Industries Limited |
Oral osmotic controlled drug delivery system
|
|
WO2003099214A2
(en)
*
|
2002-05-23 |
2003-12-04 |
Andrx Corporation |
Biguanide formulations
|
|
EP1536767B1
(en)
*
|
2002-06-17 |
2007-08-08 |
Alza Corporation |
Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
|
JP5072364B2
(ja)
*
|
2003-11-25 |
2012-11-14 |
スミスクライン ビーチャム （コーク） リミテッド |
カルベジロール遊離塩基、カルベジロール塩、無水形態またはその溶媒和物、対応する医薬組成物、制御放出処方および治療またはデリバリー方法
|
|
WO2005051325A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol compositions methods of treatment and delivery
|
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
|
EP2020990B1
(en)
|
2006-05-30 |
2010-09-22 |
Intarcia Therapeutics, Inc |
Two-piece, internal-channel osmotic delivery system flow modulator
|
|
EP2363112B8
(en)
|
2006-08-09 |
2018-11-21 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
|
MX2009011123A
(es)
|
2007-04-23 |
2009-11-02 |
Intarcia Therapeutics Inc |
Formulaciones de suspensiones de peptidos insulinotropicos y sus usos.
|
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
|
CA2757037C
(en)
|
2009-01-29 |
2019-08-06 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
MX352878B
(es)
|
2009-09-28 |
2017-12-13 |
Intarcia Therapeutics Inc |
Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
|
|
CA2807535C
(en)
|
2010-08-05 |
2019-03-19 |
Forsight Vision4, Inc. |
Injector apparatus and method for drug delivery
|
|
WO2012019176A2
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4 Inc. |
Implantable therapeutic device
|
|
CN103153316B
(zh)
|
2010-08-05 |
2015-08-19 |
弗赛特影像4股份有限公司 |
组合药物递送方法和设备
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
AU2011342893A1
(en)
|
2010-12-13 |
2013-05-02 |
Purdue Pharma L.P. |
Controlled release dosage forms
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
WO2013003620A2
(en)
|
2011-06-28 |
2013-01-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
EP2739252A4
(en)
|
2011-08-05 |
2015-08-12 |
Forsight Vision4 Inc |
SMALL MOLECULE ADMINISTRATION USING AN IMPLANTABLE THERAPEUTIC DEVICE
|
|
WO2013040247A2
(en)
|
2011-09-16 |
2013-03-21 |
Forsight Vision4, Inc. |
Fluid exchange apparatus and methods
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
WO2014160884A1
(en)
|
2013-03-28 |
2014-10-02 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
|
JP6581194B2
(ja)
|
2014-07-15 |
2019-09-25 |
フォーサイト・ビジョン フォー・インコーポレーテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ４， Ｉｎｃ． |
眼用インプラント送達装置および方法
|
|
SG11201700943TA
(en)
|
2014-08-08 |
2017-03-30 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
CA2967330A1
(en)
|
2014-11-10 |
2016-05-19 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|
|
BR112017017729A2
(pt)
|
2015-02-20 |
2018-04-10 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
forma de dosagem oral de liberação controlada de agonista de receptor gaba
|
|
MX2017015504A
(es)
|
2015-06-03 |
2018-05-15 |
Intarcia Therapeutics Inc |
Sistemas de colocacion y remoción de implante.
|
|
AU2016355345A1
(en)
|
2015-11-20 |
2018-05-31 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
|
WO2017176886A1
(en)
|
2016-04-05 |
2017-10-12 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
IL307966A
(en)
|
2017-01-03 |
2023-12-01 |
Intarcia Therapeutics Inc |
Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
|
JP7314155B2
(ja)
|
2017-11-21 |
2023-07-25 |
フォーサイト・ビジョン４・インコーポレーテッド |
膨張可能ポート送達システムのための流体交換装置及びその使用方法
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
CN110045072B
(zh)
*
|
2019-04-19 |
2023-12-05 |
禄根仪器(镇江)有限公司 |
一种药物吸收***及其吸收取样方法
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|